AMY WALL: Open Payments
NPI 1023324282 · NEWBURGH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,087 in 49 payments from 12 companies in 2025. Trend: 2023 $1,047 · 2024 $747 · 2025 $1,087
Food & beverage: $1,087
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 13 | $264 |
| Astellas Pharma US Inc | 6 | $177 |
| Ethicon US, LLC | 4 | $171 |
| Biogen, Inc. | 5 | $123 |
| MAYNE PHARMA COMMERCIAL LLC | 8 | $112 |
| Hologic Sales and Service, LLC | 4 | $87 |
| ABBVIE INC. | 2 | $41 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
| Exeltis, USA Inc. | 2 | $30 |
| Novo Nordisk Inc | 1 | $19 |
Products named: MYFEMBREE, Veozah, ZURZUVAE, STRATAFIX, DERMABOND, CoolSeal Generator, VISTASEAL, Sonata Sonography-Guided Transcervical Fibroid Ablation System.
Industry payments across IN — which companies pay providers there.
